Meningiomas harboring recurrent somatic SMO mutations are part of a larger group of samples that exhibit activation of the Hedgehog (Hh) signaling pathway, which also includes cases with somatic biallelic loss of SUFU or PRKAR1AA17D mutation14. The gene discussed is SMO; the disease is meningioma.